Skip to main content

Reforming Obamacare: The Challenge Ahead

President-Elect Donald Trump has suggested replacing Obamacare with a package of benefits that might include:
  • Permitting Insurance to be sold across state lines
  • Retention of the mandate covering pre-existing conditions
  • Allowing young people to remain on parents’ insurance
  • Creating high-risk pools to provide insurance to people with chronic diseases
  • Using Health Savings Accounts (HSAs) as an alternative to tax credits
  • Expanding the use of high-deductible plans to lower premium costs


Let’s consider some of the challenges the President-Elect and Congress will face as they craft these – and other – provisions to amend the Affordable Care Act (ACA).  

Selling Insurance Across State Lines

President-Elect Trump has been clear that he supports this idea, because it would bring more competition into state markets. 

Here’s the challenge. Insurance is regulated by the states, and some states have tighter regulations than others. To allow insurance to be sold across state lines, the Congress would have to abridge states’ rights to allow insurance from less-regulated states into states with more regulations and consumer protections. Consumers might get more products.  But they would be worse products, making consumers unhappy.

Covering Pre-Existing Conditions
Trump has also been clear that he would retain this provision.  It is a lifeline for people with chronic diseases and conditions.  However, these conditions are often expensive to cover.  Unless you mix them in a plan that captures healthier people, too, costs will rise no matter what else you do.

Allowing Children to Remain on Parents’ Insurance Until Age 26

Trump has said that he likes this Obamacare provision.  Here’s the challenge.  Keeping healthy, younger people out of the exchanges has helped to drive up the costs of the plans in the exchanges.  If you don’t move them into the insurance market as early as you can, you’re making insurance more expensive for everyone else.

Setting Up High-Risk Pools

The President-Elect has suggested that new high-risk pools could make sure that people with chronic diseases still have access to insurance.  But at what cost?  We had a high-risk pool in Connecticut when I was a state legislator in the 1970s and 1980s.  It was expensive, and the only people who chose to be in it were the ones who absolutely knew that the insurance would pay out more than the premiums cost.

Expanding Health Savings Accounts as An Alternative to Tax Credits

Health Savings Accounts – into which people deposit tax-free dollars to pay for health care costs – have been offered as an alternative to the tax credits that currently subsidize the cost of private health insurance for everyone between 100 percent and 400 percent of poverty.  This would help people earning more than 400 percent of poverty who are not covered by group plans, because they wouldn’t have to pay taxes on their insurance premiums.  But for people earning less than this, the end of the tax credits would mean that they would have to pay the full cost of their insurance. And while getting a tax deduction on anything they deposited into their HSA would help some, deductions are generally never as generous as credits.

Expanding the Use of High-Deductible Plans

President-Elect Trump has suggested coupling HSAs with the use of more high-deductible plans to lower costs.  In “exchange speak,” think more bronze plans. Here’s the way this might work.  


Assume that a single adult male making $50,000 per year buys a plan with a $10,000 deductible and pays $250 per month for the insurance.  To use an HSA to cover those costs, he would deposit $13,000 into his HSA to cover the premium and the deductible. That would reduce his taxable income to $37,000.  If he is in the 15% tax bracket, at the end of the year he would get back 15% of the $13,000 he deposited into his HSA, or $1,950.

Spending one-quarter of his income on health care to get back $1,950 would not make him feel too good about that high-deductible plan.

Any Obamacare reform will undoubtedly also at least consider repealing the individual mandate and rolling back Medicaid expansion. 

President-Elect Trump has suggested converting Medicaid to a block grant as well. Doing this could also be challenging.

In 2008, President Obama didn’t support the individual mandate, either.  Will younger, wealthier, healthier people buy insurance if they perceive they don’t have to?  We don’t know, but there is some evidence that without a mandate, they won’t.  And if they don’t, the price of insurance to everyone else will go up.

Finally, most states expanded Medicaid, including Michigan, Pennsylvania, Ohio, Iowa, and Arizona.  The federal government is covering more than 90 percent of that cost.  Trump has said that he does not want to roll back entitlements.  Neither would the voters in these states.

The Challenge Ahead

The goal of ACA was to get more people insured, using the health care financing system that was already in place. 


The challenge ahead will be to keep those people insured if ACA is changed.  Probably the best way to do this – single-payer, Medicare for all – won’t happen anytime soon.  But if the new President and Congress don’t walk a tightrope in making their changes, single-payer may come along a whole lot sooner than anyone imagines.

Comments

Popular posts from this blog

The Missing Mental Health Element in the Ferguson Story

By now, everyone has heard the news from Ferguson, Missouri.  An unarmed 18 year old named Michael Brown was shot and killed by a police officer.  Michael Brown was black. Some of the events surrounding the shooting are in dispute.  But what isn’t in dispute is that for the past two weeks, a community has been torn apart by race – a community that until recently was best known for its proximity to St. Louis and its designation as a Playful City, USA . Picture credit: Health Affairs Media reports since the August 9 th shooting have focused almost entirely on one angle – race relations.  We’ve heard about unrest in the city, the National Guard, police in riot gear, and danger in the streets.  We’ve heard about the District Attorney’s ties to law enforcement, and concerns that a too-white Grand Jury may be racially motivated not to indict the police officer involved in the deadly shooting. But the media have been strangely silent about a different angle – this comm

Celebrating Larissa Gionfriddo Podermanski Five Years Later

My daughter Larissa died of Metastatic Breast Cancer five years ago, in May of 2018.  She had only two wishes at the end. One was that we plant a tree for her. We did - in a Middletown CT city park - and it has grown straight and tall. The other was that she not be forgotten. Larissa's family and friends took pains to reassure that she could not be forgotten. If you were fortunate enough to know Larissa, you would know why. Still, I wondered how I might celebrate her a little more now that some years have passed, while sharing some of her memorable spirit with others (some who knew her and others who did not), while reminding us why she was such an extraordinary woman. In early 2017, Larissa started a blog called Metastatically Speaking, through which she chronicled her life with MBC. Unfortunately - and through no one's fault - her blog disappeared some time after her death. So, if you search for it now, you can't find it.  However, I was fortunate enough to see and retain

Judgment Day

Ironic. I was not as nervous as you would think on April 23 rd .  Martin, my mother and I drove up to Dana Farber.  All weekend I wanted plan for Poland, Barbados and Florida, as we brainstormed ideas of what could be attainable or possible. I started to realize I looked pregnant… but that couldn’t be. When the appointment began I noticed it felt like a routine visit. Everything went smoothly, but what were we focusing on? It was this: if I did nothing the outlook for me was living three weeks to a few months longer. So, is that my only option, I wanted to know?   No, I was told we can try a low dose chemo and see how it works.   Since it is low dose, they said, it won’t do much harm, but we truly don’t know how it will work. It’s not a treatment we have used a lot at low dose and technically you are in liver failure, leaving you with limited options.   Of course, the goal would still be to get you to be stable; however, this is a blind treatment. We don’t know if this approach w